IP Library › Assignment 048785/0577
Patent Assignment
Reel/Frame 048785/0577

Assignment of Assignor's Interest

Recorded: 2019-04-03 Pages: 3
Assignor
ADIMAB, LLC
Executed: 2019-04-02
Assignee
MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (3)
Compositions and Methods for the Depletion of CD117+ Cells
Anti-CD117 Antibodies and Methods of Using Same
Compositions and Methods for the Depletion of CD117+ Cells
Application: 16/168,816 →
Publication: US 2019/0144558
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 3, 2019
From: PEARSE, BRADLEY R.; BOITANO, ANTHONY; PALCHAUDHURI, RAHUL; MCDONOUGH, SEAN
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 048785/0340 →
Assignment of Assignor's Interest Apr 3, 2019
From: BELK, JONATHAN PHILIP; SMITH, MATTHEW DUNCAN
To: ADIMAB, LLC
Reel/Frame 048785/0452 →
Assignment of Assignor's Interest May 2, 2023
From: MAGENTA THERAPEUTICS, INC.
To: CRISPR THERAPEUTICS AG
Reel/Frame 063517/0097 →